Alkylation

Successful STRATCO® Alkylation Technology Startup at PetroChina Guangdong Refinery

Retrieved on: 
Wednesday, January 31, 2024
Oil, Gas, Sustainability, Environment, Other Manufacturing, Energy, Chemicals, Plastics, Green Technology, Manufacturing, PetroChina, Growth, RON, Research, Alkylation, Aptitude, Alkylation unit, Gasoline, China National Petroleum Corporation, Clean technology, HAZOP, KMTA, Renewable energy

PetroChina Guangdong (PetroChina), a subsidiary of China National Petroleum Corporation, has successfully completed and surpassed all performance guarantees for its groundbreaking 595 thousand metric tons per annum (KMTA) STRATCO® alkylation unit.

Key Points: 
  • PetroChina Guangdong (PetroChina), a subsidiary of China National Petroleum Corporation, has successfully completed and surpassed all performance guarantees for its groundbreaking 595 thousand metric tons per annum (KMTA) STRATCO® alkylation unit.
  • This successful performance test marks a significant milestone as one of the largest alkylation units operating within China.
  • “Seeing the PetroChina STRATCO® alkylation unit handedly pass all performance guarantee tests is a testament to the technology and the aptitude of the staff of the refinery.
  • Licensed and marketed by Elessent Clean Technologies, the STRATCO® alkylation technology is the world-leading alkylation technology with more than 100 licensed units worldwide and more than 915,000 bpsd (35,800 kmta) of installed capacity.

Sundyne Sponsors the UOP/Honeywell 2023 HF Alkylation User's Symposium in Colorado Springs, June 26-29

Retrieved on: 
Monday, June 19, 2023
Centrifugal pump, Hydrofluoric acid, Reliability, UOP, HF, Gasoline, NDE, HMD, Literature, Corrosion, Dicarboxylic acid, Honeywell, Alkylation, FCCU, Hydrocarbon, Safety, Oil, Refractory, Sundyne

COLORADO SPRINGS, Colo., June 19, 2023 /PRNewswire-PRWeb/ -- Sundyne, a global leader in the design and manufacture of pumps and compressors, today announced that it is sponsoring the Honeywell UOP 2023 HF Alkylation User's Symposium, taking place June 26-29 at the Cheyenne Mountain Resort in Colorado Springs, CO.    

Key Points: 
  • This session codifies lessons learned since 1992, when a refinery in Australia deployed an HMD Kontro sealless magnetic drive pump for HF Alkylation – which remains in service today.
  • The session will discuss Sundyne/HMD's innovative approach to addressing the industry-wide issues associated with casting failures for pumps handling Hydrofluoric Acid.
  • To learn more about how HMD's sealless pumps are used in HF Acid Service, please complete the HF Alkylation inquiry form or download literature from https://hmdkontro.com/hf/ .
  • To arrange a meeting with the Sundyne team to discuss HF Alkylation pumping challenges, please contact: [email protected] .

CVR Energy Proceeds with Alkylation Project Using KBR's K-SAAT Technology

Retrieved on: 
Thursday, March 16, 2023
HF, Gasoline, Alkylation, Engineering, ESG, KBR, NYSE, Oil

This phase entails the completion of engineering, design, module fabrication and construction for KBR's Solid Acid Alkylation Technology (K-SAAT™) unit to eliminate hydrofluoric (HF) acid from the refinery.

Key Points: 
  • This phase entails the completion of engineering, design, module fabrication and construction for KBR's Solid Acid Alkylation Technology (K-SAAT™) unit to eliminate hydrofluoric (HF) acid from the refinery.
  • KBR's contract includes the supply of a fully engineered and fabricated modular solution along with KBR's proprietary catalyst for the project.
  • "We view this as a landmark project for the U.S. refining industry," said Doug Kelly, KBR President, Technology.
  • "We are pleased to move forward with this important project," said Dave Lamp, President & Chief Executive Officer of CVR Energy.

Sundyne Sponsors the Oil Gas & Power World Expo 2023, March 1-3, at the Bombay Exhibition Center in Mumbai, India

Retrieved on: 
Thursday, February 23, 2023
Hydrogen, British Gas, Gas, CDU, PSA, Maintenance, P&O Maritime Logistics, Maritime, HMP, Oil, Sundyne, API, HMD, CO2, Pressure swing adsorption, Alkylation, Video game, Petroleum, Heating, ventilation, and air conditioning

MUMBAI, India, Feb. 23, 2023 /PRNewswire-PRWeb/ -- Sundyne, a global leader in the design and manufacture of pumps and compressors, today announced that it is exhibiting at the Oil Gas & Power World Expo 2023, taking place March 1-3 at the Bombay Exhibition Center, Goregaon (East) in Mumbai, India. This expo features several co-located events, including: the Oil & Gas World Expo; Power World Expo; Refining & Petrochemicals 2023, the Gas World-Tech Expo, and the Maritime & Logistics World Expo. Sundyne's pumps & compressors are used to support applications in each of these industries. Sundyne's technology will be on display in Stand 1 C-1A.

Key Points: 
  • This expo features several co-located events, including: the Oil & Gas World Expo; Power World Expo; Refining & Petrochemicals 2023, the Gas World-Tech Expo, and the Maritime & Logistics World Expo.
  • The Oil Gas & Power World Expo 2023 brings together stakeholders from the entire energy ecosystem – including upstream, midstream and downstream oil & gas; power generation, transmission and distribution; as well as chemical & petrochemical production.
  • At Oil Gas & Power World Expo 2023, Sundyne will showcase:
    Sundyne Integrally Geared Centrifugal Compressors: used for CO2 capture and for Pressure Swing Adsorption (PSA) blower applications.
  • Visit Sundyne at Oil Gas & Power World Expo 2023, in Stand 1 C-1A.

Veolia Water Technologies & Solutions and OLI Systems to Jointly Accelerate Digital Transformation for the Oil and Gas Industry with Water Chemistry Insights

Retrieved on: 
Wednesday, January 25, 2023
Cloud, FCC, Thermodynamics, OLI, Alkylation, Chemistry, Risk, Water, Veolia Water Technologies & Solutions, Oil, Veolia

"Veolia has a broad portfolio of solutions for the refining industry, and this collaboration with OLI will allow us to provide our customers with a consultative offering to provide enhanced diagnostics, system optimization, and alternative treatments.

Key Points: 
  • "Veolia has a broad portfolio of solutions for the refining industry, and this collaboration with OLI will allow us to provide our customers with a consultative offering to provide enhanced diagnostics, system optimization, and alternative treatments.
  • "OLI Systems is building strategic global relationships to accelerate industrial digital transformation.
  • The democratization of OLI capabilities with anytime, anywhere access to water chemistry-based process insights dramatically increases the productivity of field engineers across the globe," says Vineeth Ram, Chief Revenue Officer, OLI Systems.
  • "Together with Veolia, we are enabling improved efficiency of refinery and petrochemical operations, while mitigating risk of downtime by optimizing chemical treatment programs and, lowering operations costs."

U.S. FDA Approves Clinical Trial Application for IASO Bio's BCMA CAR-T CT103A for Relapsed/Refractory Multiple Myeloma

Retrieved on: 
Thursday, December 22, 2022
CD19, Alkylation, EHA, NMOSD, Neuromyelitis optica spectrum disorder, Multiple myeloma, Patient, Proteasome inhibitor, Maxwell, SAN, Food, European Hematology Association, CR, CAR, CRS, Bone marrow, Bone, MTTR, Degenerative disease, BTD, ORR, Anemia, Fragment crystallizable region, Breakthrough therapy, National Medical Products Administration, New Drug Application, Conference, FDA, Safety, Kidney failure, CD8A, Multimedia, Investigational New Drug, ODD, IND, MM, NMPA, NDA, Cytokine release syndrome, B-cell maturation antigen, MRD, BCMA, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Pharmaceutical industry, Drug discovery

Multiple myeloma is a deadly blood cancer that often infiltrates the bone marrow causing anemia, kidney failure, immune problems, and bone fractures.

Key Points: 
  • Multiple myeloma is a deadly blood cancer that often infiltrates the bone marrow causing anemia, kidney failure, immune problems, and bone fractures.
  • In February 2022, CT103A was granted the "orphan drug designation (ODD)" by the FDA for the treatment of multiple myeloma.
  • In June 2022, CT103A was accepted by the NMPA for the NDA application for the treatment of relapsed/refractory multiple myeloma and included in the priority review.
  • The NMPA accepted the New Drug Application for equecabtagene autoleucel for the treatment of relapsed/refractory multiple myeloma (R/R MM).

Global Iodine Market Report 2022 to 2027 - Featuring Algorta Norte, Eskay Iodine, Iofina and Nippoh Chemicals Among Others - ResearchAndMarkets.com

Retrieved on: 
Thursday, November 17, 2022
Chemicals, Plastics, Manufacturing, Dairy, Alkylation, Egg, Breast, Iodised salt, Seaweed, Seafood, Intellectual, Goitre, Vegetable, Metabolism, Bandage, Protein, Growth, Hypothyroidism, COVID-19, Triiodothyronine, CT, Compound, Salt, I2, Iodine

These insights are included in the report as a major market contributor.

Key Points: 
  • These insights are included in the report as a major market contributor.
  • Iodine (I2) is a trace element naturally found in dairy products, seafood, seaweed, eggs, and vegetables.
  • This report provides an analysis of the key trends in each sub-segment of the global iodine market, along with forecasts at the global, regional and country level from 2022-2027.
  • The report has categorized the market based on source, form and application.

Global Ethylene Market to 2027 - Growing Production of Shale Gas is Increasing Ethane Production & Positively Influence the Market - ResearchAndMarkets.com

Retrieved on: 
Friday, September 23, 2022
Chemicals, Plastics, Manufacturing, Ethylene oxide, Alkylation, Petroleum, Polymerization, Growth, Polyethylene, Smell, Market, Plastic, Taste, Water, Natural gas, Plant, Ethane, Chemical, Petrochemical, Landscape maintenance, Industry

The increase in demand for ethylene oxide for the manufacturing of plastics expected to boost the global ethylene market growth during this forecast period.

Key Points: 
  • The increase in demand for ethylene oxide for the manufacturing of plastics expected to boost the global ethylene market growth during this forecast period.
  • Furthermore, the growing production of shale gas is increasing ethane production will positively influence the market growth.
  • Also, low production cost of the gas will drive the growth of the global ethylene market.
  • Fluctuation in the price of raw material is major restraint which expected to hamper the global ethylene market growth over the forecast period.

Global Cytotoxic Drugs Market Estimated to Reach $14,885.2 Million by 2028 and Grow at 1.2% CAGR in the 2021-2028 Timeframe [202-Pages] | Report by Research Dive

Retrieved on: 
Monday, June 13, 2022
Center for Urban and Regional Analysis, Health, Breast cancer, Pancreatic cancer, COVID-19, Lung, Lung cancer, Mark (given name), Route of administration, Alkylation, Awareness, Growth, Prostate cancer, Research, Incidence, NEW, Prevalence, Administration, CAGR, Cancer, Fine chemical, Pharmaceutical industry, Antimetabolite

NEW YORK, June 13, 2022 /PRNewswire/ -- Research Dive has added a new report to its offering titled, "Cytotoxic Drugs Market by Drug Type (Alkylating Agents, Antitumor Antibiotics, Antimetabolites, Plant Alkaloids, and Other Drug Types), Route of Administration (Parenteral and Oral), Application (Breast Cancer, Prostate Cancer, Lung Cancer, Pancreatic Cancer, and Other Applications), and Regional Analysis (North America, Europe, Asia-Pacific, and LAMEA): Global Opportunity Analysis and Industry Forecast, 2021–2028".

Key Points: 
  • - The global cytotoxic drugs market is expected to grow by 2028 due to the increasing prevalence of cancer.
  • According to the report, the global cytotoxic drugs market is expected to gather a revenue of $14,885.2 million by 2028, growing at a CAGR of 1.2% during the 2021-2028 timeframe.
  • Restraints: Low penetration of the cytotoxic drugs, especially in low-income countries, may hamper the growth trajectory of the cytotoxic drugs market.
  • By drug type, the antimetabolites drugs sub-segment of the cytotoxic drugs market is estimated to have a dominating share and garner $6,908.1 million by 2028.

Global Refinery Catalysts Market Trajectory & Analytics Report 2022: Projected Rebound in Shale Production Post COVID-19 in 2022 to Positively Impact Demand for Refinery Catalysts - ResearchAndMarkets.com

Retrieved on: 
Tuesday, April 19, 2022
Oil, Gas, Energy, CAGR, Growth, FCC, Alkylation, Industry, European emission standards, Gasoline, Oil, Pet, Speciality chemicals

The "Refinery Catalysts - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Refinery Catalysts - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
  • Alkylation Catalysts, one of the segments analyzed in the report, is projected to grow at a 2.8% CAGR to reach US$918.9 Million by the end of the analysis period.
  • This segment currently accounts for a 44.9% share of the global Refinery Catalysts market.
  • In the global Hydrotreating Catalysts segment, USA, Canada, Japan, China and Europe will drive the 2.9% CAGR estimated for this segment.